Acorda Therapeutics reported $-13503000 in EBIT for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -113016000 68.36M
Acorda Therapeutics ACOR:US $ -13503000 3.34M
Agios Pharmaceuticals AGIO:US $ -101145000 3.68M
ALKERMES ALKS:US -26585000 28.97M
Amgen AMGN:US $ 2500M 196M
Anika Therapeutics ANIK:US $ -3554000 5.35M
Aptinyx Inc APTX:US $ -19379000 207K
Arrowhead Research ARWR:US $ 41.55M 104.87M
Biogen BIIB:US $ 531.5M 11.7M
Biomarin Pharmaceutical BMRN:US $ 29.33M 95.21M
Cara Therapeutics CARA:US $ -27911000 5.61M
Clovis Oncology CLVS:US $ -50359000 2.35M
Cytokinetics CYTK:US $ -77857000 58.95M
Enanta Pharmaceuticals ENTA:US $ -33847000 3.44M
Gilead Sciences GILD:US $ 2897M 1957M
GlaxoSmithKline GSK:LN 2.42B 724M
Halozyme Therapeutics HALO:US $ 75.67M 19.14M
Heron Therapeutics HRTX:US $ -62923000 9.39M
Insmed INSM:US $ -101451000 1.41M
Ligand Pharmaceuticals LGND:US $ -9306000 22.04M
Mannkind MNKD:US $ -23239000 2.29M
Merck MRK:GR 1.2B 186M
Moderna Inc MRNA:US 4.23B 1.18B
Neurocrine Biosciences NBIX:US $ 3.1M 60.9M
Novartis NOVN:VX 3.15B 266M
Pfizer PFE:US $ 9995M 4136M
Teva Pharmaceutical TEVA:IT 789M 182M
Ultragenyx Pharmaceutical RARE:US $ -136632000 34.07M
Vertex Pharmaceuticals VRTX:US $ 1033.4M 157.68M